These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases. Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577 [TBL] [Abstract][Full Text] [Related]
5. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor. Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288 [TBL] [Abstract][Full Text] [Related]
6. Circulating activated T cell subsets in autoimmune thyroid diseases: differences between untreated and treated patients. Ohashi H; Okugawa T; Itoh M Acta Endocrinol (Copenh); 1991 Nov; 125(5):502-9. PubMed ID: 1684685 [TBL] [Abstract][Full Text] [Related]
7. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism. Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555 [TBL] [Abstract][Full Text] [Related]
8. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis. Okumura M; Hidaka Y; Kuroda S; Takeoka K; Tada H; Amino N J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377 [TBL] [Abstract][Full Text] [Related]
9. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis. Chan JY; Walfish PG Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193 [TBL] [Abstract][Full Text] [Related]
10. Studies of human peripheral blood mononuclear cells (PBMC) from patients with subacute thyroiditis in severe combined immunodeficient (SCID) mice: less production of human interferon gamma than that seen for Graves' disease. Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Miller N; Volpé R Horm Metab Res; 1994 Sep; 26(9):419-23. PubMed ID: 7835825 [TBL] [Abstract][Full Text] [Related]
11. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells. McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263 [TBL] [Abstract][Full Text] [Related]
12. Normal immunoregulation of in vitro antibody secretion in autoimmune thyroid disease. MacLean DB; Miller KB; Brown R; Reichlin S J Clin Endocrinol Metab; 1981 Oct; 53(4):801-5. PubMed ID: 6457056 [TBL] [Abstract][Full Text] [Related]
13. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis. Wall JR; Chartier B J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155 [TBL] [Abstract][Full Text] [Related]
14. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Nanba T; Watanabe M; Inoue N; Iwatani Y Thyroid; 2009 May; 19(5):495-501. PubMed ID: 19415997 [TBL] [Abstract][Full Text] [Related]
15. Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate. Solerte SB; Precerutti S; Gazzaruso C; Locatelli E; Zamboni M; Schifino N; Bonacasa R; Rondanelli M; Taccani D; Ferrari E; Fioravanti M Eur J Endocrinol; 2005 May; 152(5):703-12. PubMed ID: 15879355 [TBL] [Abstract][Full Text] [Related]
16. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry. Chan JY; Walfish PG J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483 [TBL] [Abstract][Full Text] [Related]
17. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness. Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491 [TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of thyroid-stimulating antibody measurement using Chinese hamster ovary cells expressing human thyrotropin receptors. Murakami M; Miyashita K; Kakizaki S; Saito S; Yamada M; Iriuchijima T; Takeuchi T; Mori M Eur J Endocrinol; 1995 Jul; 133(1):80-6. PubMed ID: 7627342 [TBL] [Abstract][Full Text] [Related]
19. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases. Mariotti S; Caturegli P; Barbesino G; Marinò M; Del Prete GF; Chiovato L; Tonacchera M; De Carli M; Pinchera A Clin Endocrinol (Oxf); 1992 Nov; 37(5):415-22. PubMed ID: 1486691 [TBL] [Abstract][Full Text] [Related]
20. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay. Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]